(Q46671479)

English

Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis

scientific article published in April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

1 reference

based on heuristic

inferred from title

author name string

M E Perry

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

Anne Stirling

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

J A Hunter

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

publication date

1 April 2008

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

Clinical Rheumatology

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

27

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

923-925

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/18379834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid automated enzyme immunoassay of serum amyloid A

1 reference

https://pubmed.ncbi.nlm.nih.gov/18379834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eprodisate for the treatment of renal disease in AA amyloidosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18379834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/18379834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyloid precursors and amyloidosis in inflammatory arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18379834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/18379834

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-008-0875-3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18379834

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46671479&oldid=2125456678"